| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.058 | 0.9 |